MicroPort Scientific Corporation

Leading Chinese developer of interventional medical products with life-saving solutions and treatments

A leading Chinese medical technology company focused on high-end interventional medical devices

MicroPort is a leading medical device company focused on developing, manufacturing, and marketing high-end medical devices globally. The company has a diverse product portfolio, with its products being used once every 30 seconds on average across more than 2,000 major hospitals in China and in 24 other countries in APAC, South America, and Europe. A majority of MicroPort’s revenue is derived from drug eluting stents, but robust growth in other cardiovascular, endovascular, and neurovascular devices combined with new market entries into electrophysiological devices and surgical management have significantly accelerated its global diversification. Through its significant R&D spending, MicroPort is dedicated to becoming a leading global enterprise capable of providing the best, and yet most affordable, medical products and technologies to serve patients throughout the world. MicroPort is headquartered in Shanghai, China.

Transaction Summary

  • Essex Woodlands acquired a minority stake in MicroPort in 2007, with the company subsequently growing revenues by more than 2x in just four years
  • MicroPort successfully completed its IPO in HongKong in late 2010

Related News

“Essex Woodlands was the only US investor in MicroPort prior to MicroPort going public. Essex Woodlands has a deep understanding of our products and growth potential and provided valuable support in the development of the company, especially as it transitioned into a public company. ”

Michael Zhang

Former President, MicroPort Chairman, Otsuka China Investments